Brimonidine Tartrate Solution
Product Images NDC 61314-144

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 61314-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.15percent5mlcarton

This is information on Brimonidine Tartrate, an ophthalmic solution used for topical use in the eyes. It is marketed by Sandoz Inc. The solution contains 0.15% brimonidine tartrate (1.5 mg/mL) along with povidone, boric acid, sodium borate, calcium chloride, magnesium chloride, potassium chloride, mannitol, Sodium chloride, POLYQUAD 0.001% and purified water. The usual dosage is 1 drop three times daily approximately eight hours apart. It is advised to store the solution at 15°-25°C (59-77°F) and keep it out of reach of children.*

FDA Label Image

Chemicalstructure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.